382 related articles for article (PubMed ID: 29905933)
61. Minimally invasive cytologic evaluation leading to the diagnosis of TFE3-rearranged renal cell carcinoma: A case report.
Gama A; Sukhanova M; Choy B
Diagn Cytopathol; 2022 Dec; 50(12):E382-E385. PubMed ID: 35975764
[TBL] [Abstract][Full Text] [Related]
62. MiT family translocation renal cell carcinomas: A 15th anniversary update.
Gandhi JS; Malik F; Amin MB; Argani P; Bahrami A
Histol Histopathol; 2020 Feb; 35(2):125-136. PubMed ID: 31489603
[TBL] [Abstract][Full Text] [Related]
63. Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature.
Peckova K; Vanecek T; Martinek P; Spagnolo D; Kuroda N; Brunelli M; Vranic S; Djuricic S; Rotterova P; Daum O; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Dubova M; Kalusova K; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2014 Dec; 18(6):351-7. PubMed ID: 25438924
[TBL] [Abstract][Full Text] [Related]
64. A Tale of 2 Morphologies: Diagnostic Pitfalls in
Sharma AE; Parilla M; Wanjari P; Segal JP; Antic T
Int J Surg Pathol; 2021 Feb; 29(1):21-29. PubMed ID: 32886007
[TBL] [Abstract][Full Text] [Related]
65. Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
Song HC; Sun N; Zhang WP; He L; Fu L; Huang C
J Pediatr Surg; 2014 Apr; 49(4):539-42. PubMed ID: 24726108
[TBL] [Abstract][Full Text] [Related]
66. Chameleon TFE3-translocation RCC and How Gene Partners Can Change Morphology: Accurate Diagnosis Using Contemporary Modalities.
Tretiakova MS
Adv Anat Pathol; 2022 May; 29(3):131-140. PubMed ID: 35180736
[TBL] [Abstract][Full Text] [Related]
67.
Kmeid M; Akgul M
Int J Surg Pathol; 2023 Aug; 31(5):509-520. PubMed ID: 35912477
[No Abstract] [Full Text] [Related]
68. Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.
Just PA; Letourneur F; Pouliquen C; Dome F; Audebourg A; Biquet P; Vidaud M; Terris B; Sibony M; Pasmant E
Genes Chromosomes Cancer; 2016 Jun; 55(6):541-8. PubMed ID: 26998913
[TBL] [Abstract][Full Text] [Related]
69. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
[TBL] [Abstract][Full Text] [Related]
70. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
71. A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion.
Fukuda H; Kato I; Furuya M; Tanaka R; Takagi T; Kondo T; Nagashima Y
Virchows Arch; 2019 Mar; 474(3):389-393. PubMed ID: 30552521
[TBL] [Abstract][Full Text] [Related]
72. AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Zheng L; Zhang X; Pan X; Huang Z; Zhang M; Xian J; Wei Y; Nie L; Zhang M; Gong J; Chen X; Zhou Q; Zeng H; Chen N
Mod Pathol; 2023 Nov; 36(11):100303. PubMed ID: 37580017
[TBL] [Abstract][Full Text] [Related]
73. Clinicopathologic Classification of Renal Cell Carcinoma in Patients ≤40 Years Old From Peru.
Kamanda S; Huanca-Amesquita L; Milla E; Argani P; Epstein JI
Int J Surg Pathol; 2024 Feb; 32(1):35-45. PubMed ID: 37062985
[TBL] [Abstract][Full Text] [Related]
74. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
[TBL] [Abstract][Full Text] [Related]
75. Microphthalmia family of transcription factors associated renal cell carcinoma.
Xie L; Zhang Y; Wu CL
Asian J Urol; 2019 Oct; 6(4):312-320. PubMed ID: 31768316
[TBL] [Abstract][Full Text] [Related]
76. A case of PSF-TFE3 gene fusion in Xp11.2 renal cell carcinoma with melanotic features.
Zhan HQ; Chen H; Wang CF; Zhu XZ
Hum Pathol; 2015 Mar; 46(3):476-81. PubMed ID: 25582502
[TBL] [Abstract][Full Text] [Related]
77. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
[TBL] [Abstract][Full Text] [Related]
78. The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma.
Zhu QQ; Wang ZQ; Zhu WR; Chen WX; Wu JT
Acta Radiol; 2013 Apr; 54(3):355-62. PubMed ID: 23446748
[TBL] [Abstract][Full Text] [Related]
79. [Study on clinicopathologic features and immunophenotype of 114 cases of renal cell carcinoma].
Zou H; Pang LJ; Hu WH; Li F; Li HA; Jiang JF; Liang WH; Sun ZZ; Wang C; Lang JY
Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):726-31. PubMed ID: 19094705
[TBL] [Abstract][Full Text] [Related]
80. MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical management.
Rizzo M; Pezzicoli G; Santoni M; Caliò A; Martignoni G; Porta C
Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188823. PubMed ID: 36240899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
